首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >Glycemic control and the risk of death in 1,484 patients receiving maintenance hemodialysis.
【24h】

Glycemic control and the risk of death in 1,484 patients receiving maintenance hemodialysis.

机译:接受维持性血液透析的1484名患者的血糖控制和死亡风险。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: It is controversial whether tighter glycemic control is associated with better clinical outcomes in people with kidney failure. We aim to determine whether worse glycemic control, measured using serum glucose and hemoglobin A(1c) (HbA(1c)) levels, is independently associated with higher mortality in patients undergoing maintenance hemodialysis. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: 1,484 patients starting maintenance hemodialysis therapy in Alberta, Canada, between 2001 and 2007. PREDICTOR: Serum glucose and HbA(1c) levels. OUTCOME: All-cause mortality. MEASUREMENTS: Monthly casual glucose levels from specimens drawn immediately before the first dialysis treatment were averaged over 3 months before and after hemodialysis therapy initiation. Similarly, monthly HbA(1c) values in patients with or at risk of diabetes were averaged. RESULTS: Overall, median age was 66 years, 41% were women, 75% were white, and 55% had diabetes. All-cause mortality during 8 years (median, 1.5 years) was 43%; it was 49% in those with diabetes. There was no relation between average glucose level and mortality in unadjusted analysis (HR, 1.00 per 18 mg/dL [1 mmol/L]; P = 0.4) or after adjustment for confounders (HR, 0.98 per 18 mg/dL; 95% CI, 0.96-1.01; P = 0.2). Higher HbA(1c) level was not associated with mortality when analyzed in the unadjusted analysis (HR, 1.01 per 1% HbA(1c); P = 0.9) or after adjustment for confounders (HR, 0.98 per 1% HbA1c; 95% CI, 0.88-1.08; P = 0.7). Results were similar when HbA(1c) values were divided into prespecified categories (adjusted P > 0.6 for trend). Markers of malnutrition-inflammation (albumin, hemoglobin, and white blood cell values) or the presence of diabetes did not influence the relation between glycemic control and death (all P for interaction > 0.2). LIMITATIONS: Registry data; casual serum glucose measurements; HbA(1c) values available for only a subset of participants. CONCLUSIONS: Higher casual glucose and HbA(1c) levels were not associated with mortality in maintenance hemodialysis patients with or without diabetes. This may have implications for recommended glycemic targets, quality indicators, and how best to assess glycemic control in this high-risk population.
机译:背景:在肾衰竭患者中,更严格的血糖控制与更好的临床结局是否相关还存在争议。我们旨在确定使用血清葡萄糖和血红蛋白A(1c)(HbA(1c))水平测得的较差的血糖控制是否与维持性血液透析患者的较高死亡率独立相关。研究设计:回顾性队列研究。地点和参与者:2001年至2007年之间,加拿大艾伯塔省开始进行维持性血液透析治疗的1,484例患者。预测者:血清葡萄糖和HbA(1c)水平。结果:全因死亡率。测量:在首次进行透析治疗之前和之后的三个月内,平均从第一次透析治疗之前抽取的标本中每月的随意葡萄糖水平平均。同样,对患有糖尿病或有糖尿病风险的患者每月HbA(1c)值进行平均。结果:总体而言,中位年龄为66岁,女性为41%,白人为75%,糖尿病为55%。 8年(中位数为1.5年)期间的全因死亡率为43%;在糖尿病患者中占49%。未经调整的分析(HR,每18 mg / dL [1.00 mmol / L]为1.00; P = 0.4)或混杂因素调整后的平均血糖水平与死亡率之间无相关性(HR,每18 mg / dL为0.98; 95%) CI,0.96-1.01; P = 0.2)。在未经调整的分析中(HR,每1%HbA(1c)1.01; P = 0.9)或对混杂因素进行调整后(HR,每1%HbA1c 0.98); 95%CI,较高的HbA(1c)水平与死亡率无关,0.88-1.08; P = 0.7)。将HbA(1c)值划分为预先指定的类别时,结果相似(趋势调整P> 0.6)。营养不良-炎症(白蛋白,血红蛋白和白细胞值)或糖尿病的标志物不影响血糖控制与死亡之间的关系(相互作用的所有P> 0.2)。限制:注册表数据;偶然的血糖测量; HbA(1c)值仅适用于一部分参与者。结论:维持性血液透析患者有或没有糖尿病,较高的偶然血糖和HbA(1c)水平与死亡率无关。这可能对建议的血糖目标,质量指标以及如何最好地评估该高危人群的血糖控制有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号